Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma.
Filippo TorrigianiGiorgio RomanelliPaola RoccabiancaElisabetta TreggiariPublished in: JFMS open reports (2019)
Treatment with neoadjuvant doxorubicin can be considered in cases of inoperable STSs in order to cytoreduce the tumour and improve the chances of achieving complete surgical margins. The role of adjuvant chemotherapy in this setting remains unclear.